1. Home
  2. SEMR vs LQDA Comparison

SEMR vs LQDA Comparison

Compare SEMR & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEMR
  • LQDA
  • Stock Information
  • Founded
  • SEMR 2008
  • LQDA 2004
  • Country
  • SEMR United States
  • LQDA United States
  • Employees
  • SEMR N/A
  • LQDA N/A
  • Industry
  • SEMR EDP Services
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEMR Technology
  • LQDA Health Care
  • Exchange
  • SEMR Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • SEMR 1.3B
  • LQDA 1.7B
  • IPO Year
  • SEMR 2021
  • LQDA 2018
  • Fundamental
  • Price
  • SEMR $9.41
  • LQDA $19.11
  • Analyst Decision
  • SEMR Buy
  • LQDA Strong Buy
  • Analyst Count
  • SEMR 8
  • LQDA 9
  • Target Price
  • SEMR $17.00
  • LQDA $27.67
  • AVG Volume (30 Days)
  • SEMR 798.5K
  • LQDA 2.4M
  • Earning Date
  • SEMR 08-04-2025
  • LQDA 08-06-2025
  • Dividend Yield
  • SEMR N/A
  • LQDA N/A
  • EPS Growth
  • SEMR N/A
  • LQDA N/A
  • EPS
  • SEMR 0.05
  • LQDA N/A
  • Revenue
  • SEMR $396,021,000.00
  • LQDA $14,144,000.00
  • Revenue This Year
  • SEMR $21.85
  • LQDA $189.27
  • Revenue Next Year
  • SEMR $18.50
  • LQDA $402.79
  • P/E Ratio
  • SEMR $198.37
  • LQDA N/A
  • Revenue Growth
  • SEMR 22.75
  • LQDA N/A
  • 52 Week Low
  • SEMR $7.90
  • LQDA $8.26
  • 52 Week High
  • SEMR $18.74
  • LQDA $20.33
  • Technical
  • Relative Strength Index (RSI)
  • SEMR 51.03
  • LQDA 72.69
  • Support Level
  • SEMR $8.60
  • LQDA $18.98
  • Resistance Level
  • SEMR $10.00
  • LQDA $14.67
  • Average True Range (ATR)
  • SEMR 0.32
  • LQDA 0.95
  • MACD
  • SEMR 0.09
  • LQDA 0.59
  • Stochastic Oscillator
  • SEMR 57.14
  • LQDA 81.43

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: